Trigran Investments’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-168,400	Closed	-$1.62M	–	18
2025 Q4	$1.62M	Sell	168,400 -1,452,815	-90%	-$13.9M	0.32%	16
2025 Q3	$15.2M	Sell	1,621,215 -415,296	-20%	-$3.97M	2.76%	14
2025 Q2	$21.5M	Sell	2,036,511 -5,342	-0.3%	-$67.4K	3.74%	13
2025 Q1	$30.7M	Buy	2,041,853 +20,075	+1%	+$334K	4.52%	12
2024 Q4	$33.3M	Sell	2,021,778 -102,682	-5%	-$2.03M	3.83%	13
2024 Q3	$52.5M	Sell	2,124,460 -11,772	-0.6%	-$305K	5.74%	8
2024 Q2	$54.1M	Buy	2,136,232 +63,808	+3%	+$1.65M	5.66%	8
2024 Q1	$52.6M	Sell	2,072,424 -66,630	-3%	-$1.61M	5.1%	9
2023 Q4	$48.5M	Sell	2,139,054 -77,965	-4%	-$1.61M	4.7%	9
2023 Q3	$41.3M	Buy	2,217,019 +410,390	+23%	+$8.51M	4.4%	11
2023 Q2	$46.9M	Buy	1,806,629 +208,015	+13%	+$5.57M	4.53%	10
2023 Q1	$45.9M	Buy	1,598,614 +34,073	+2%	+$1.01M	4.43%	11
2022 Q4	$46.3M	Buy	1,564,541 +72,449	+5%	+$2.06M	4.64%	11
2022 Q3	$35.5M	Buy	1,492,092 +337,909	+29%	+$7.78M	4.08%	12
2022 Q2	$25.8M	Buy	1,154,183 +199,384	+21%	+$4.45M	3%	14
2022 Q1	$24M	Buy	954,799 +362,611	+61%	+$11.1M	2.43%	17
2021 Q4	$21.2M	Buy	592,188 +165,595	+39%	+$6.63M	2.03%	17
2021 Q3	$18.2M	Buy	426,593 +242,240	+131%	+$9.98M	2%	16
2021 Q2	$7.98M	Buy	+184,353	New	+$7.85M	0.88%	16